MediWound Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.8	9.16	11.87	33.9	11.05
Short-Term Investments	48.34	34.01	29.84	-	-
Cash & Short-Term Investments	53.14	43.16	41.71	33.9	11.05
Cash Growth	23.12%	3.48%	23.05%	206.85%	-48.82%
Accounts Receivable	1.62	4.8	3.7	9.33	1.78
Other Receivables	1.11	1.51	1.67	0.83	0.93
Total Trade Receivables	2.73	6.31	5.37	10.16	2.71
Inventory	4.09	2.69	2.85	1.96	1.2
Total Current Assets	59.96	52.16	49.7	45.84	14.95
Net Property, Plant & Equipment	25.79	20.8	15.93	3.58	4.03
Other Intangible Assets	0.03	0.1	0.17	0.23	0.3
Other Long-Term Assets	0.47	0.44	0.44	0.18	0.47
Total Assets	86.26	73.5	66.46	50.02	19.74
Accounts Payable	7.65	5.28	5.53	5.66	4.69
Unearned Revenue	-	-	-	-	0.12
Other Current Liabilities	18.06	21.26	12.6	22.01	6.03
Total Current Liabilities	25.71	26.54	18.13	12.06	10.72
Other Long-Term Liabilities	16.92	15.8	16.74	11.44	13.49
Total Long-Term Liabilities	16.92	15.8	16.74	27.05	13.61
Total Liabilities	42.62	42.34	34.86	39.1	24.33
Common Stock	0.26	0.22	0.18	0.14	0.08
Additional Paid-in Capital	272.33	236	206.25	178.88	143.87
Accumulated Other Comprehensive Income	-0.03	-0.01	-0.02	-0.01	-0.02
Retained Earnings	-228.93	-205.05	-174.82	-168.11	-148.51
Shareholders' Equity	43.63	31.15	31.6	10.91	-4.58
Total Liabilities & Equity	86.26	73.5	66.46	50.02	19.74
Net Cash (Debt)	53.14	43.16	41.71	33.9	11.05
Net Cash Growth	23.12%	3.48%	23.05%	206.85%	-48.82%
Net Cash Per Share	4.67	4.33	4.63	6.80	2.84
Book Value	43.63	31.15	31.6	10.91	-4.58
Book Value Per Share	3.84	3.13	3.51	2.19	-1.18
Tangible Book Value	43.6	31.05	31.43	10.68	-4.88
Tangible Book Value Per Share	3.83	3.12	3.49	2.14	-1.25

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q